Primary FDA-Approved Indications
Use during symptomatic periods; combine with non‑medicine supports for best outcomes.
Allergic rhinitis (seasonal/perennial)
FDA ApprovedChildren and adolescentsFirst-line
Evening dosing if drowsy; pair with saline rinses and allergen control